BMYBristol-Myers Squibb CompanyHealthcare · Drug Manufacturers - Generalas of 2026-09-16
Horizon

Issued 2026-09-16 at $63.60 · now $63.60 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, BMY has typically landed between $57.64 and $71.03 — a range of −9.4% to +11.7% from the issuance price $63.60.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,685 overlapping 1 month windows · 2008-01-022026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($63.60) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where BMY has typically landed a month from the 2026-09-16 close of $63.6 — the range is history, not a prediction.

$57.64worst · -9.4%$71.03best · +11.7%
  • now $63.6 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $63.72 (+0.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $60.86$66.58
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $57.64$71.03
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,685 windows spanning 2008-01-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-21−29.3%−29.3%+0.0%
2020-02-19−25.8%−25.8%+0.0%
2020-02-20−25.7%−25.7%+0.7%
3 best
2020-03-23+32.4%+0.0%+34.0%
2020-03-19+27.5%−4.9%+27.5%
2009-03-03+27.3%+0.0%+27.3%

4,685 overlapping windows · 2008-01-022026-09-16 · not cherry-picked

Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.

$126.8B
market cap
$3.56
EPS (TTM)
17.4
P/E (TTM)
2026-07-30
next earnings
Revenue$48.2B
'20'25
Net income$7.1B
'20'25
Free cash flow$12.8B
'20'25
Net margin · by yr14.6%
'20'25
ROE · by yr38.2%
'20'25
Debt / equity · by yr2.55
'20'25

Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.

iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 54 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.
now $63.60$23.04$268.98
  • DCF (intrinsic)$252.02
  • Peer P/E × EPS · sector median 27.4× · n=54$97.69
  • Analyst target · range $40.00$75.00$65.00
  • Current price · last close 2026-09-16$63.60

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
39%
−1.7%
n=18
Feb
63%
+1.9%
n=19
Mar
63%
+2.4%
n=19
Apr
37%
−2.0%
n=19
May
42%
−0.2%
n=19
Jun
63%
+1.0%
n=19
Jul
53%
+2.4%
n=19
Aug
63%
−0.2%
n=19
Sep
63%
+0.7%
n=19
Oct
44%
+1.9%
n=18
Nov
67%
+2.4%
n=18
Dec
72%
+3.4%
n=18

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$68$412026-09-09: 1 insider sale, $403K — Massacesi Cristian2026-08-25: 1 insider sale, $34K — Holzer Phil M2026-04-01: 2 insider sales, $1.9M — Elkins David V …2025-09-02: 1 insider sale, $2.7M — Elkins David V2025-08: 1 open-market sale, $17K2025-09: 1 open-market sale, $2.7M2026-04: 2 open-market sales, $1.9M2026-08: 1 open-market sale, $34K2026-09: 1 open-market sale, $403K↑ buys↓ salesofficer Massacesi Cristian — Sale on 2026-09-09, filed 1 day after the tradeofficer Holzer Phil M — Sale on 2026-08-25, filed 1 day after the tradedirector Elkins David V — Sale on 2026-04-01, filed 1 day after the tradedirector Elkins David V — Sale on 2026-04-01, filed 1 day after the tradedirector Elkins David V — Sale on 2025-09-02, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-09Massacesi CristianofficerSale6,249 @ $64.57$403K−25.0% of holdingnot yet — horizon still opennot yet — horizon still open18,748Form 4 · filed 1 day after the trade
2026-08-25Holzer Phil MofficerSale500 @ $67.50$34K−2.9% of holdingnot yet — horizon still opennot yet — horizon still open16,862Form 4 · filed 1 day after the trade
2026-04-01Elkins David VdirectorSale25,519 @ $61.60$1.6M−13.5% of holding−14.7%not yet — horizon still open163,729Form 4 · filed 1 day after the trade
2026-04-01Elkins David VdirectorSale4,481 @ $62.05$278K−2.7% of holding−14.7%not yet — horizon still open159,248Form 4 · filed 1 day after the trade
2025-09-02Elkins David VdirectorSale56,000 @ $47.33$2.7M−25.1% of holding−4.6%+27.2%167,379Form 4 · filed 1 day after the trade
2025-08-02Short Bartie WendyofficerSale378 @ $44.23$17K−6.9% of holding+4.2%+17.1%5,066Form 4 · filed 3 days after the trade
2025-05-09Hickey BenjamindirectorSale97 @ $38.01$4K−100.0% of holding+0.7%−16.3%0Form 4 · filed 4 days after the trade
2025-04-25Hirawat SamitdirectorPurchase4,250 @ $47.58$202K+5.4% of holding−9.5%−29.7%83,513Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

292 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-01Short Bartie WendyofficerOption exercise1,23613,317Form 4
2026-09-01Short Bartie WendyofficerWithheld for tax63312,684Form 4
2026-09-01Short Bartie WendyofficerOption exercise1,2360Form 4
2026-08-01Massacesi CristianofficerWithheld for tax26,17524,997Form 4
2026-08-01Gallman CariofficerWithheld for tax54313,649Form 4
2026-08-01Gallman CariofficerOption exercise1,06114,192Form 4
2026-08-01Massacesi CristianofficerOption exercise51,172153,519Form 4
2026-08-01Massacesi CristianofficerOption exercise51,17251,172Form 4
2026-08-01Gallman CariofficerOption exercise1,0610Form 4
2026-06-30Samuels Theodore R. IIdirectorAward / grant88970,361Form 4
2026-06-30Rice Derica WdirectorAward / grant67341,069Form 4
2026-06-30Arduini Peter JdirectorAward / grant60772,816Form 4
2026-06-30McMullen Michael R.directorAward / grant60716,333Form 4
2026-06-30YALE PHYLLIS RdirectorAward / grant60744,986Form 4
2026-06-15Haller Julia AdirectorOption exercise20,46034,079Form 4
2026-06-15Haller Julia AdirectorOption exercise20,4600Form 4
2026-06-03Short Bartie WendyofficerWithheld for tax3,87612,081Form 4
2026-06-03Short Bartie WendyofficerOption exercise8,04015,957Form 4
2026-06-03Short Bartie WendyofficerOption exercise8,0408,040Form 4
2026-05-01Lenkowsky AdamofficerWithheld for tax59919,706Form 4
2026-05-01Lenkowsky AdamofficerOption exercise1,3731,375Form 4
2026-05-01Lenkowsky AdamofficerOther acquisition20320,305Form 4
2026-05-01Lenkowsky AdamofficerOption exercise1,37320,508Form 4
2026-04-01Shanahan KarinofficerWithheld for tax1,69225,888Form 4
2026-04-01Shanahan KarinofficerOption exercise3,3070Form 4
2026-04-01Shanahan KarinofficerOption exercise3,30727,580Form 4
2026-03-31Samuels Theodore R. IIdirectorAward / grant84568,728Form 4
2026-03-31Rice Derica WdirectorAward / grant63939,964Form 4
2026-03-31YALE PHYLLIS RdirectorAward / grant57743,904Form 4
2026-03-31McMullen Michael R.directorAward / grant57715,557Form 4
2026-03-31Arduini Peter JdirectorAward / grant57771,435Form 4
2026-03-10BOERNER CHRISTOPHER S.directorWithheld for tax10,51817,029Form 4
2026-03-10Elkins David VdirectorWithheld for tax10,240189,248Form 4
2026-03-10Shanahan KarinofficerWithheld for tax5,14524,273Form 4
2026-03-10BOERNER CHRISTOPHER S.directorWithheld for tax4,63221,451Form 4
2026-03-10Meyers Gregory ScottofficerWithheld for tax4,26730,361Form 4
2026-03-10Plenge Robert MdirectorWithheld for tax3,17221,528Form 4
2026-03-10Lenkowsky AdamofficerWithheld for tax3,12517,086Form 4
2026-03-10BOERNER CHRISTOPHER S.directorWithheld for tax3,0736,984Form 4
2026-03-10BOERNER CHRISTOPHER S.directorWithheld for tax3,0064,051Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.

As of 2026-09-16 · point-in-time by filed date

Purchase clusters · 2015–2021 (dev)+45 bp/mo vs baseline · up-rate 59.3% vs 57.3% · n=31,607 cluster ticker-weeks
Purchase clusters · 2022–2026 (out-of-sample)+32 bp/mo vs baseline · up-rate 54.0% vs 53.3% · n=27,793

A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).

'23 Q'23 Q'24 Q'24 Q'24 Q'24 Q'25 Q'25 Q'25 Q'25 Q'26 Q'26 Q'26 Qpurchases ▲ / sales ▼ ($ vol)
MemberChamberTypeFiledTradedSize
Alan ArmstrongSenatepurchase2026-07-212026-03-27$1–15K
Ro KhannaHousesale2026-07-062026-06-16$1–15K
Mike KellyHousesale2026-06-112026-05-07$15–50K
Ro KhannaHousepurchase2026-06-092026-05-15$1–15K
Ro KhannaHousepurchase2026-05-112026-04-13$1–15K
Ro KhannaHousepurchase2026-03-092026-02-05$1–15K
Ro KhannaHousesale2026-02-062026-01-29$15–50K
Ro KhannaHousepurchase2026-02-062026-01-23$1–15K
Julie JohnsonHousesale2026-01-152025-12-18$1–15K
Julia LetlowHousesale2026-01-132025-04-28$1–15K
Julia LetlowHousepurchase2026-01-132024-10-23$1–15K
Gilbert CisnerosHousepurchase2026-01-122025-12-19$1–15K
Gilbert CisnerosHousepurchase2025-12-152025-11-12$1–15K
Julie JohnsonHousesale2025-12-112025-11-13$1–15K

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.